InspireMD (NSPR) stock price, revenue, and financials

InspireMD market cap is $10.6 m, and annual revenue was $3.72 m in FY 2019

$10.6 M

NSPR Mkt cap, 23-Sept-2020

$313 K

InspireMD Revenue Q2, 2020
InspireMD Gross profit (Q2, 2020)-120 K
InspireMD Gross profit margin (Q2, 2020), %(38.3%)
InspireMD Net income (Q2, 2020)-2.5 M
InspireMD EBIT (Q2, 2020)-2.4 M
InspireMD Cash, 30-Jun-202013.9 M
InspireMD EV-2.8 M

InspireMD Revenue

InspireMD revenue was $3.72 m in FY, 2019

Embed Graph

InspireMD Income Statement

Quarterly

USDQ2, 2011Q3, 2011Q1, 2012Q2, 2013Q3, 2013Q1, 2014Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Revenue

1.0m2.0m1.1m1.4m1.5m1.6m1.5m193.0k273.0k477.0k685.0k632.0k563.0k540.0k469.0k569.0k640.0k718.0k1.0m1.0m769.0k415.0k1.4m939.0k1.0m313.0k

Cost of goods sold

640.0k801.0k574.0k547.0k674.0k750.0k625.0k584.0k349.0k514.0k897.0k543.0k497.0k478.0k438.0k495.0k493.0k565.0k714.0k726.0k571.0k488.0k912.0k811.0k739.0k433.0k

Gross profit

400.0k1.2m564.0k803.0k840.0k802.0k857.0k(391.0k)(76.0k)(37.0k)(212.0k)89.0k66.0k62.0k31.0k74.0k147.0k153.0k293.0k277.0k198.0k(73.0k)442.0k128.0k295.0k(120.0k)

Gross profit Margin, %

38%60%50%59%55%52%58%(203%)(28%)(8%)(31%)14%12%11%7%13%23%21%29%28%26%(18%)33%14%29%(38%)

Sales and marketing expense

617.0k302.0k445.0k1.2m804.0k830.0k1.3m1.9m1.8m1.0m995.0k588.0k386.0k401.0k329.0k532.0k632.0k671.0k492.0k580.0k605.0k634.0k620.0k537.0k624.0k377.0k

R&D expense

750.0k547.0k1.3m1.3m907.0k1.5m2.6m2.4m2.5m1.4m747.0k781.0k478.0k301.0k289.0k350.0k403.0k288.0k252.0k230.0k416.0k1.1m865.0k442.0k523.0k444.0k

General and administrative expense

1.2m2.5m1.9m1.8m2.3m2.3m2.5m2.4m2.1m2.0m1.6m1.7m1.6m1.2m1.2m1.6m1.4m1.3m1.5m940.0k1.2m1.3m1.1m1.1m1.2m1.5m

Operating expense total

2.6m3.3m3.7m5.2m4.1m4.7m6.4m6.8m6.4m4.9m3.4m3.5m2.5m1.9m1.8m2.5m2.4m2.2m2.2m1.8m2.2m3.1m2.6m2.1m2.3m2.3m

Depreciation and amortization

42.0k

EBIT

(2.2m)(2.1m)(3.1m)(4.4m)(3.2m)(3.9m)(5.5m)(7.2m)(6.5m)(4.9m)(3.6m)(3.4m)(2.4m)(1.8m)(1.8m)(2.4m)(2.3m)(2.1m)(2.0m)(1.5m)(2.0m)(3.1m)(2.2m)(2.0m)(2.0m)(2.4m)

EBIT margin, %

(209%)(108%)(275%)(323%)(212%)(250%)(373%)(3749%)(2374%)(1025%)(522%)(540%)(424%)(333%)(377%)(422%)(358%)(290%)(194%)(147%)(257%)(754%)(161%)(213%)(195%)(781%)

Interest expense

72.0k108.0k11.0k1.1m1.3m352.0k359.0k361.0k301.0k275.0k246.0k179.0k188.0k197.0k119.0k73.0k

Interest income

6.0k7.0k

Pre tax profit

(2.2m)(2.3m)(3.1m)(1.9m)(4.9m)(3.9m)(5.9m)(7.6m)(6.8m)(5.2m)(3.9m)(3.6m)(2.6m)(2.0m)(2.0m)(2.6m)(2.3m)(2.1m)(2.4m)(627.0k)(2.0m)(3.2m)(2.2m)(2.1m)(2.5m)

Income tax expense

10.0k25.0k25.0k42.0k(18.0k)3.0k20.0k2.0k16.0k(17.0k)2.0k1.0k1.0k

Net Income

(2.3m)(2.3m)(3.1m)(1.9m)(4.9m)(3.9m)(6.0m)(7.6m)(6.8m)(5.2m)(3.9m)(3.6m)(2.6m)(2.0m)(2.0m)(2.6m)(2.3m)(2.1m)(2.4m)(627.0k)(2.0m)(3.2m)(2.2m)(2.1m)(2.0m)(2.5m)

InspireMD Balance Sheet

Annual

USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

5.1m10.3m17.5m3.3m7.5m3.7m9.4m5.5m

Accounts Receivable

2.3m1.8m1.9m405.0k643.0k716.0k823.0k

Prepaid Expenses

72.0k93.0k141.0k75.0k62.0k81.0k87.0k

Inventories

2.1m1.7m1.6m753.0k500.0k533.0k1.1m1.2m

Current Assets

9.8m14.3m21.6m4.6m8.6m5.2m11.4m7.8m

PP&E

420.0k462.0k652.0k242.0k472.0k379.0k476.0k421.0k547.0k

Total Assets

10.5m16.0m24.0m5.8m9.4m6.1m12.3m9.9m

Accounts Payable

814.0k441.0k1.6m512.0k618.0k328.0k929.0k646.0k

Short-term debt

94.0k4.2m

Current Liabilities

3.4m3.6m6.1m6.9m4.8m2.5m2.9m3.1m

Long-term debt

5.0m1.1m653.0k

Non-Current Liabilities

270.0k7.1m9.2m1.8m587.0k624.0k605.0k1.4m

Total Debt

94.0k5.0m5.3m653.0k

Total Liabilities

3.7m10.6m15.3m8.7m5.4m3.1m3.5m4.5m

Common Stock

7.0k7.0k3.0k1.0k1.5m4.0k3.9m

Additional Paid-in Capital

43.4m49.1m91.0m120.0m136.0m143.1m156.4m163.0m

Retained Earnings

(36.6m)(43.7m)(82.3m)(123.0m)(131.9m)(140.4m)(147.6m)(157.6m)

Total Equity

6.8m5.4m8.6m(2.9m)4.0m2.7m8.8m5.4m

Financial Leverage

1.5 x3 x2.8 x-2 x2.3 x2.2 x1.4 x1.8 x

Quarterly

USDQ2, 2011Q3, 2011Q1, 2012Q2, 2013Q3, 2013Q1, 2014Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Cash

8.1m7.5m3.4m5.4m2.5m11.4m13.7m9.0m5.0m13.2m9.8m6.5m2.0m885.0k10.5m8.6m6.9m4.8m4.6m6.4m11.2m5.8m4.8m7.2m3.1m13.9m

Accounts Receivable

614.0k1.8m2.0m1.3m2.1m2.1m1.5m493.0k397.0k719.0k728.0k546.0k432.0k542.0k471.0k451.0k538.0k754.0k916.0k710.0k464.0k861.0k796.0k856.0k416.0k

Prepaid Expenses

71.0k103.0k89.0k94.0k91.0k144.0k110.0k215.0k138.0k109.0k76.0k62.0k41.0k107.0k21.0k73.0k109.0k53.0k71.0k145.0k66.0k44.0k155.0k63.0k40.0k

Inventories

1.5m1.9m2.0m2.0m2.0m1.4m1.3m1.5m1.7m1.8m1.2m1.1m511.0k387.0k365.0k329.0k429.0k576.0k517.0k637.0k816.0k1.4m1.2m1.3m1.2m1.4m

Current Assets

10.8m11.5m7.8m9.1m7.1m15.6m17.2m11.6m7.7m16.0m12.0m8.6m3.3m1.9m11.6m9.6m8.0m6.2m6.2m8.2m13.1m8.0m7.2m9.6m5.4m15.9m

PP&E

304.0k346.0k465.0k479.0k467.0k591.0k624.0k663.0k636.0k584.0k546.0k516.0k436.0k412.0k379.0k496.0k459.0k495.0k444.0k431.0k400.0k452.0k513.0k538.0k496.0k459.0k

Total Assets

11.3m12.1m8.5m11.6m9.8m17.7m19.5m14.0m9.9m17.7m13.6m9.8m4.2m3.0m12.5m10.5m8.9m7.1m7.3m9.5m13.9m10.1m9.3m11.6m7.4m17.7m

Accounts Payable

763.0k562.0k333.0k501.0k416.0k850.0k1.4m1.5m1.5m665.0k2.7m834.0k453.0k1.2m409.0k351.0k473.0k402.0k512.0k476.0k456.0k872.0k618.0k687.0k562.0k458.0k

Short-term debt

268.0k183.0k6.5m7.4m4.0m4.3m3.9m3.7m

Current Liabilities

3.9m3.6m3.4m9.5m10.9m4.0m7.5m9.1m9.6m7.5m7.3m7.5m7.1m7.5m5.6m2.3m2.6m2.7m3.0m2.5m2.4m2.6m1.9m2.3m2.6m3.2m

Long-term debt

3.2m1.1m1.1m699.0k544.0k476.0k

Non-Current Liabilities

264.0k257.0k317.0k1.9m2.3m637.0k8.4m7.6m6.7m4.8m3.9m2.8m584.0k662.0k604.0k540.0k572.0k610.0k1.5m629.0k608.0k1.8m1.8m1.4m1.3m1.3m

Total Debt

268.0k183.0k5.6m6.5m7.4m7.2m4.3m3.9m3.7m1.1m1.1m699.0k544.0k476.0k

Total Liabilities

4.2m3.9m3.7m11.4m13.2m4.7m15.9m16.8m16.3m12.3m11.2m7.6m8.1m6.2m2.8m3.2m3.3m4.5m3.1m3.0m4.4m3.7m3.7m3.9m4.5m

Common Stock

6.0k6.0k7.0k2.0k2.0k3.0k3.0k3.0k4.0k7.0k7.0k1.0k1.0k1.3m1.0k1.0k1.0k3.5m6.5m4.0k871.9k1.4m3.5m4.3m3.0k

Additional Paid-in Capital

33.3m36.6m44.6m53.3m54.6m89.9m91.9m93.0m96.2m118.0m118.9m119.6m122.2m122.5m135.8m142.2m142.5m142.6m143.8m147.5m156.3m156.4m158.6m163.0m163.1m175.3m

Retained Earnings

(26.1m)(28.4m)(39.8m)(53.1m)(58.0m)(76.9m)(88.3m)(95.8m)(102.6m)(112.6m)(116.5m)(120.1m)(125.6m)(127.6m)(129.6m)(134.5m)(136.8m)(138.9m)(142.7m)(143.4m)(145.4m)(150.8m)(153.0m)(155.1m)(159.6m)(162.1m)

Total Equity

7.2m8.2m4.8m204.0k(3.4m)13.0m3.6m(2.8m)(6.4m)5.4m2.4m(3.4m)(5.1m)6.2m7.7m5.7m3.8m1.0m4.1m11.0m5.6m5.6m7.9m3.5m13.2m

Debt to Equity Ratio

1.2 x

Debt to Assets Ratio

0.7 x

Financial Leverage

1.6 x1.5 x1.8 x56.8 x-2.9 x1.4 x5.4 x-5 x-1.6 x3.3 x5.7 x-1.3 x-0.6 x2 x1.4 x1.6 x1.9 x7 x2.3 x1.3 x1.8 x1.7 x1.5 x2.1 x1.3 x

InspireMD Cash Flow

Quarterly

USDQ2, 2011Q3, 2011Q1, 2012Q2, 2013Q3, 2013Q1, 2014Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Net Income

(4.1m)(6.4m)(3.1m)(9.4m)(14.3m)(3.9m)(6.0m)(13.5m)(20.3m)(5.2m)(9.1m)(12.7m)(2.6m)(4.6m)(6.6m)(2.6m)(4.9m)(6.9m)(2.4m)(3.0m)(5.0m)(3.2m)(5.4m)(7.5m)(2.0m)(4.5m)

Depreciation and Amortization

38.0k52.0k34.0k95.0k146.0k50.0k56.0k122.0k181.0k75.0k135.0k195.0k48.0k95.0k143.0k42.0k84.0k127.0k41.0k79.0k115.0k35.0k73.0k114.0k51.0k88.0k

Accounts Receivable

(103.0k)(50.0k)(242.0k)551.0k(322.0k)(389.0k)361.0k1.4m1.5m(84.0k)(93.0k)(29.0k)(141.0k)(27.0k)(137.0k)(115.0k)(95.0k)(182.0k)(111.0k)(273.0k)(67.0k)252.0k(145.0k)(80.0k)(33.0k)407.0k

Inventories

(51.0k)(233.0k)(238.0k)201.0k250.0k79.0k(89.0k)174.0k695.0k843.0k242.0k366.0k388.0k171.0k71.0k(76.0k)16.0k(104.0k)(283.0k)(313.0k)(84.0k)(149.0k)34.0k(166.0k)

Accounts Payable

(340.0k)(541.0k)(481.0k)60.0k(65.0k)19.0k(218.0k)(94.0k)(75.0k)(244.0k)(418.0k)(75.0k)(59.0k)686.0k(103.0k)(267.0k)(145.0k)(216.0k)184.0k148.0k128.0k(57.0k)(311.0k)(242.0k)(84.0k)(188.0k)

Cash From Operating Activities

(1.8m)(3.9m)(1.6m)(5.8m)(8.6m)(3.3m)(3.7m)(8.4m)(14.3m)(4.6m)(7.0m)(9.4m)(1.9m)(2.7m)(5.6m)(2.8m)(4.3m)(6.4m)(1.8m)(4.0m)(5.8m)(3.5m)(6.4m)(8.2m)(2.4m)(3.8m)

Purchases of PP&E

(42.0k)(98.0k)(79.0k)(87.0k)(118.0k)(80.0k)(13.0k)(93.0k)(105.0k)(1.0k)(1.0k)(12.0k)(11.0k)(13.0k)(153.0k)(164.0k)(237.0k)(1.0k)(28.0k)(30.0k)(66.0k)(165.0k)(231.0k)

Cash From Investing Activities

(144.0k)120.0k(48.0k)(193.0k)(267.0k)(110.0k)(34.0k)(65.0k)(67.0k)(11.0k)(2.0k)9.0k90.0k110.0k81.0k(156.0k)(195.0k)(282.0k)(12.0k)(41.0k)(105.0k)(224.0k)(318.0k)(3.0k)(34.0k)

Long-term Borrowings

(188.0k)(281.0k)(94.0k)(290.0k)(891.0k)(1.8m)(2.7m)(988.0k)(1.3m)(1.7m)(2.2m)(2.2m)(2.2m)

Cash From Financing Activities

9.4m10.8m(94.0k)1.0m1.0m(77.0k)(115.0k)1.8m11.6m10.5m9.6m516.0k180.0k12.8m4.0m3.9m3.9m2.7m6.8m13.4m16.0k2.0m6.3m3.0k12.2m

Net Change in Cash

7.4m6.8m(1.7m)(4.9m)(7.8m)(3.4m)(3.8m)(8.5m)(12.6m)6.9m3.5m209.0k(1.3m)(2.4m)7.2m1.1m(637.0k)(2.8m)927.0k2.7m7.5m(3.6m)(4.6m)(2.2m)(2.4m)8.3m

InspireMD Ratios

USDQ2, 2011

Financial Leverage

1.6 x